Woodline Partners’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.99M Buy
1,401,945
+533
+0% +$2.3K 0.02% 586
2026
Q1
$5.42M Buy
1,401,412
+451
+0% +$1.85K 0.02% 646
2025
Q4
$5.86M Buy
+1,400,961
New +$5.42M 0.02% 591

Other funds holding PGEN

Woodline Partners's PGEN Position: Q2 2026 in Review

Woodline Partners increased its Precigen (PGEN) stake by 0.04% in Q2 2026, buying an estimated $2.3K and bringing the position to 1,401,945 shares worth $7.99M. The position accounts for 0.02% of the portfolio, ranked #586.

Woodline Partners first reported a position in PGEN in Q4 2025 and has held it in 3 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Woodline Partners held 1,401,945 shares of Precigen worth $7.99M as of Q2 2026.
  • Woodline Partners bought 533 Precigen shares in Q2 2026, an estimated $2.3K.
  • Precigen made up 0.02% of Woodline Partners's portfolio in Q2 2026, its #586 holding.
  • Woodline Partners first reported a position in Precigen in Q4 2025 and has held it in 3 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.